Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis-Reference-Cited by-同舟云学术

Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis

Published:2023-04 Issue:4 Volume:21 Page:1043-1054
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Zheng Ze,Mukhametova Liliya,Boffa Michael B.,Moore Ernest E.,Wolberg Alisa S.,Urano Tetsumei,Kim Paul Y.

Publisher

Elsevier BV

Subject

Hematology

Reference147 articles.

1. Structure and function of the plasminogen/plasmin system;Castellino;Thromb Haemost,2005

2. Evaluation of and recommendation for the nomenclature of the CPB2 gene product (also known as TAFI and proCPU): communication from the SSC of the ISTH;Foley;J Thromb Haemost,2015

3. Structure-function relationships in thrombin-activatable fibrinolysis inhibitor;Plug;J Thromb Haemost,2016

4. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays;Gonzalez;Ann Surg,2016

5. Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection;Wright;J Am Coll Surg,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH;Journal of Thrombosis and Haemostasis;2024-07

2. TGFβ1 plasma levels and clot lysis assay to better characterize patients after a first unprovoked episode of pulmonary embolism;2024-05-16

3. Evaluation of thrombomodulin/thrombin activatable fibrinolysis inhibitor function in plasma using tissue-type plasminogen activator-induced plasma clot lysis time;Research and Practice in Thrombosis and Haemostasis;2024-05

4. Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model;Journal of Thrombosis and Haemostasis;2024-01

5. Validation of the time to attain maximal clot amplitude after reaching maximal clot formation velocity parameter as a measure of fibrinolysis using rotational thromboelastometry and its application in the assessment of fibrinolytic resistance in septic patients: a prospective observational study: communication from the ISTH SSC Subcommittee on Fibrinolysis;Journal of Thrombosis and Haemostasis;2023-12